City Debates Animal Research Plan

CAMBRIDGE, MASS.—City officials here are wrestling with a proposal to place experiments involving animals under the control of a new council-appointed body that would have the right to delay or veto any work it did not like. The city council is in the midst of hearings leading to a possible vote on two ordinances relating to animal research at Harvard University, MIT and other private institutions within the city limits. The first proposal would seek to ensure that all laboratories are

Written byRobin Webster
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

CAMBRIDGE, MASS.—City officials here are wrestling with a proposal to place experiments involving animals under the control of a new council-appointed body that would have the right to delay or veto any work it did not like.

The city council is in the midst of hearings leading to a possible vote on two ordinances relating to animal research at Harvard University, MIT and other private institutions within the city limits. The first proposal would seek to ensure that all laboratories are following NIH guidelines on the care of animals through periodic, unannounced inspections. The second measure would create an apparatus regulate work with animals. Animal rights groups have pledged to gather signatures for a referendum if the council fails to act.

“We have no major objections to the ordinance proposed by council members Alice Wolf and Francis Duehay except for the fact that it would allow the city manager to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies